Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Inventory (2020 - 2025)

NeuroPace (NPCE) has 6 years of Change in Inventory data on record, last reported at -$1.2 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 190.31% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached $3.7 million, up 51.9%, while the annual FY2025 figure was $3.7 million, 51.9% up from the prior year.
  • Change in Inventory reached -$1.2 million in Q4 2025 per NPCE's latest filing, down from $1.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.8 million in Q2 2025 and bottomed at -$1.2 million in Q4 2025.
  • Average Change in Inventory over 5 years is $553900.0, with a median of $305500.0 recorded in 2022.
  • Peak YoY movement for Change in Inventory: crashed 269.06% in 2023, then surged 25690.91% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $718000.0 in 2021, then soared by 62.81% to $1.2 million in 2022, then increased by 29.94% to $1.5 million in 2023, then decreased by 10.99% to $1.4 million in 2024, then crashed by 190.31% to -$1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$1.2 million in Q4 2025, $1.8 million in Q3 2025, and $2.8 million in Q2 2025.